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Abstract 
Background: Although oxygen is generally administered in a liberal manner in the perioperative setting, the effects 
of oxygen administration on dynamic cardiovascular parameters, filling status and cerebral perfusion have not been 
fully unraveled. Our aim was to study the acute hemodynamic and microcirculatory changes before, during and after 
arterial hyperoxia in mechanically ventilated patients after coronary artery bypass grafting (CABG) surgery.
Methods: This was a single-center physiological study in a tertiary care ICU in the Netherlands. Twenty-two patients 
scheduled for ICU admission after elective CABG were enrolled in the study between September 2014 and September 
2015.
In the ICU, patients were exposed to a fraction of inspired oxygen (FiO2) of 90% allowing a 15-min wash-in period. 
Various hemodynamic parameters were measured using direct pressure signals and continuous arterial waveform 
analysis at three sequential time points: before, during and after hyperoxia.
Results: During a 15-min exposure to a fraction of inspired oxygen (FiO2) of 90%, the partial pressure of arterial 
oxygen (PaO2) and arterial oxygen saturation (SaO2) were significantly higher. The systemic resistance increased 
(P < 0.0001), without altering the heart rate. Stroke volume variation and pulse pressure variation decreased slightly. 
The cardiac output did not significantly decrease (P = 0.08). Mean systemic filling pressure and arterial critical closing 
pressure increased (P < 0.01), whereas the percentage of perfused microcirculatory vessels decreased (P < 0.01). Other 
microcirculatory parameters and cerebral blood flow velocity showed only slight changes.
Conclusions: We found that short-term hyperoxia affects hemodynamics in ICU patients after CABG. This was trans-
lated in several changes in central circulatory variables, but had only slight effects on cardiac output, cerebral blood 
flow and the microcirculation.
Clinical trial registration Netherlands Trial Register: NTR5064
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Background
During and after coronary artery bypass grafting 
(CABG), patients are supported with mechanical ven-
tilation and supplemental oxygen. Despite its lifesaving 
characteristics and key role in the treatment of vasodila-
tory shock, oxygen therapy may harbor considerable risks 
given the relationship between prolonged hyperoxia, lung 
injury and adverse outcome [1–5]. The effects of supple-
mental oxygen may be even more pertinent during car-
diovascular events considering the direct effects of high 
arterial oxygen concentrations on the vascular tone [6, 
7]. Arterial hyperoxia has the potential to alter hemody-
namics and has been associated with adverse outcomes 
and mortality after cardiac arrest, myocardial infarction, 
stroke, brain injury and during mechanical ventilation 
[8–14], yet not during cardiopulmonary bypass [15, 16]. 
It is well established that high oxygen concentrations 
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induce vasoconstriction and increase the resistance of the 
systemic circulation. However, the effects on vital param-
eters may be diverse and the venous and arterial aspects 
of the circulation have not been clearly distinguished in 
previous studies. Furthermore, the microcirculation may 
react differently than systemic hemodynamics [17].
Achieving hemodynamic stabilization is an important 
clinical prerequisite for early extubation and dismissal 
from the intensive care unit (ICU) after cardiothoracic 
surgery. Any intervention that influences hemodynam-
ics and blood flow to the bypassed myocardial territories 
may impact functional recovery and requires optimal 
fine-tuning to achieve the best outcome. Although oxy-
gen is generally administered in a liberal manner in the 
perioperative setting, the unraveling of the effects of oxy-
gen administration on dynamic cardiovascular param-
eters, filling status and cerebral perfusion may provide 
novel insights in the pathophysiological mechanisms 
involved in hyperoxic exposure. Our aim was to study the 
acute hemodynamic and microcirculatory changes dur-
ing increased oxygen supply in mechanically ventilated 
ICU patients after CABG surgery.
Methods
Participants
Adult patients with symptomatic coronary artery dis-
ease without recent myocardial infarction scheduled for 
ICU admission after coronary artery bypass surgery were 
screened for eligibility. Patients with congestive heart 
failure, severe arrhythmias, intracardiac shunts, extensive 
peripheral arterial occlusive disease, symptomatic pul-
monary disease, aortic aneurysm and/or significant val-
vular disease were not considered for inclusion. Patients 
with signs of severe hemodynamic instability (e.g., rapid 
changes in vascular resistance, use of inotropic agents) 
during ICU admission were excluded. Study approval was 
granted by the local medical ethics committee (LUMC 
P14.046), and all patients signed informed consent. The 
study was registered with the Netherlands Trial Register, 
number NTR5064, registration date February 2015.
Measurements
Anesthesia during surgery was maintained with propofol 
and sufentanil. Ventilation was adjusted to achieve nor-
mocapnia. FiO2 was 0.4, and a positive end-expiratory 
pressure of 5 cm H2O was applied. Directly after surgery, 
patients were admitted to the ICU and received standard 
postoperative care. Continuous infusion of propofol and 
sufentanil was maintained for all patients, and no bolus 
medications (fluids, vasoactive or sedative agents) were 
administered.
Mean arterial blood pressure (MAP) was measured 
via a 20-G radial arterial catheter inserted by Seldinger 
technique. Central venous pressure (CVP) was meas-
ured with a central venous catheter inserted in the right 
internal jugular vein (MultiCath venous catheter, Vigon 
GmbH & Co, Aachen, Germany). Pressure transducers 
(PX600F, Edwards Lifesciences) for the arterial and cen-
tral venous signals were referenced to the intersection of 
the anterior axillary line and the fifth intercostal space. 
The airway pressure was measured at the entrance of 
the endotracheal tube and balanced at zero level against 
ambient air. Standard electrocardiogram leads were used 
to monitor heart rate. Body temperature was measured 
using a rectal temperature probe.
Beat-to-beat values of cardiac output (CO), stroke 
volume, stroke volume variation (SVV), pulse pressure 
variation (PPV) and heart rate (HR) were obtained by 
Modelflow using continuous arterial waveform analysis 
as previously described [18, 19]. Hemodynamics were 
also monitored by the LiDCOplus monitor (LiDCO 
Group Plc., London, UK).
Before starting the protocol, the mechanical ventilation 
in volume-controlled mode was switched to airway pres-
sure release ventilation (APRV), with settings adjusted 
to achieve the same minute ventilation, which allows for 
external control of the ventilator (Evita 4, Dräger AG, 
Lübeck, Germany). A computer program was used to 
control the ventilator as described previously [20]. Dur-
ing the study interval, all patients were hemodynamically 
stable and ventilator settings, sedation and vasoactive 
therapy remained unchanged.
At least three videos of ten sequences (40 frames each) 
visualizing different sites of the sublingual microcircula-
tion were recorded per patient per time point by the same 
dedicated researcher using sidestream dark field (SDF) 
imaging with the MicroScan Video Microscope (Micro-
Vision Medical BV, Amsterdam, The Netherlands). The 
three best quality videos from representative multiple site 
imaging were analyzed, and calculated parameters were 
averaged. Previously suggested key points for optimal 
image acquisition were considered, and maximal efforts 
were undertaken to avoid pressure artifacts and eliminate 
secretions [21]. SDF imaging data were recorded and ana-
lyzed using real-time quality feedback on adequate focus, 
contrast and stability with GlycoCheck (GlycoCheck BV, 
Maastricht, The Netherlands), as described previously 
[22]. The GlycoCheck software automatically calculates 
the perfused boundary region (PBR), which is a previ-
ously validated dimension of the permeable part of the 
endothelial glycocalyx that does allow red blood cell pen-
etration [23, 24]. The red blood cell (RBC) filling percent-
age is calculated an estimate for microvascular perfusion. 
Recorded videos were also imported for offline analy-
sis in Automated Vascular Analysis (AVA) software 4.1 
(MicroVision Medical BV). The software automatically 
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separates outcome parameters for large (mostly venules) 
or small (mostly capillaries) vessels using a diameter cut-
off value of 20 μm. Total vessel density (TVD), perfused 
vessel density (PVD), valid vessel density (VVD) and De 
Backer Score were calculated as measures of microvas-
cular vessel density; the percentage of perfused vessels 
(%PV) was calculated as the number of vessels continu-
ously perfused divided by the total number of vessels of 
the same type. The heterogeneity index was defined as 
the difference between maximal and minimal propor-
tions of perfused vessels evaluated at each visualized area 
divided by the mean value of the areas [25].
Blood flow velocity (BFV) in the right middle cerebral 
artery (MCA) was measured at an insonation depth of 
50–52  mm by transcranial Doppler (TCD) monitoring 
using a Pioneer TC 4040. When the optimal TCD signal 
was achieved, a 2-MHz TCD transducer probe was fixed 
over the temporal window using an adjustable headset 
(Marc 500, Spencer Technologies, Nicolet Biomedical).
Experimental procedure
Approximately one hour after ICU admission the experi-
mental procedures were initiated. All measurements 
were performed with patients in supine position at three 
sequential time points: pre-intervention, during interven-
tion and post-intervention. Before the intervention (T1), 
FiO2 was titrated to a level targeting a partial pressure of 
arterial oxygen (PaO2) between 67.5  mmHg (9  kPa) and 
82.5 mmHg (11 kPa) and a complete set of hemodynamic 
measurements was performed. The intervention (T2) 
commenced by increasing the FiO2 to 0.9, and after a 
15-min wash-in period, all hemodynamic measurements 
were repeated. Thereafter (T3), the FiO2 was decreased 
by targeting baseline PaO2 levels, and after 15-min wash-
out period, the final control measurements were com-
pleted. Before, during and after the intervention, arterial 
blood gas samples were analyzed to determine arterial 
oxygenation.
Four 12-second inspiratory hold maneuvers were 
applied using ventilator plateau pressures of 5, 15, 25 and 
35  cm H2O as previously reported [20]. Each successive 
inspiratory hold was performed when the initial hemo-
dynamic steady state was reestablished. When the pla-
teau pressure increases, CVP increases concomitantly, 
whereas CO and MAP decrease with a short delay, reach-
ing a steady state at 7–10  s after inflation. From these 
steady state measurements, a venous return curve was 
constructed by fitting a linear regression line through four 
values of CVP and CO. The extrapolated value at zero 
flow is the mean systemic filling pressure (Pmsf). Simi-
larly, the ventricular output curve was fitted through the 
values of MAP and CO, where the regression line crosses 
the zero flow intercept at the critical closing pressure (Pcc) 
[19].
The resistance of the systemic circulation (Rsys) was 
calculated as the ratio of the pressure difference between 
MAP and mean CVP, and CO. The resistance at the arte-
rial and venous side of the circulation was also sepa-
rately calculated as resistance for ventricular output 
Rvo = (MAP − Pcc)/CO and resistance for venous return 
Rvr = (Pmsf − CVP)/CO [26].
Statistical analysis
As this was an exploratory physiological intervention 
study studying multiple hemodynamic parameters, we 
did not specifically rely on sample size calculation for one 
single outcome.
The intervention (T2, hyperoxia) and post-intervention 
measurements (T3, normoxia) were compared to base-
line (T1, normoxia) measurements, using a paired t tests 
or Wilcoxon signed-rank test, depending on the underly-
ing distribution.
Multivariate linear mixed models with random effects 
per patient were used to compare the exposure (T2) with 
the non-exposure (T1 and T3) measurements, to account 
for within-subject correlation and were adjusted for age, 
temperature, the administered dose of propofol and nor-
epinephrine, and the achieved levels of arterial carbon 
dioxide (PaCO2) and hemoglobin (Hb).
To account for multiple testing, the indicated levels of 
statistical significance were lowered to 0.01. All statistical 
analyses were conducted using R version 3.2.1 (R Foun-
dation for Statistical Computing, Vienna, Austria).
Results
Patients were screened for eligibility from September 
2014 until September 2015. Four patients were excluded 
due to severe postoperative hemodynamic or respira-
tory instability in the ICU. Baseline characteristics of the 
twenty-two included patients are listed in Table  1. All 
participating patients were free of surgical complications, 
fully recovered from anesthesia within 8 h after surgery 
and were discharged from the ICU on the first postopera-
tive day. During the experimental procedure, all patients 
received a glucose 2.5% in 0.45% saline solution at 
84 ml/h, propofol (range 200–400 mg h−1) and sufentanil 
(range 5–25  µg  h−1). Two patients additionally received 
norepinephrine (0.02 and 0.04 µg kg−1 min−1) at a con-
stant rate in order to keep the blood pressure in a similar 
range (MAP higher than 65 mmHg) as the other included 
patients during the experimental procedure. This was 
accounted for in the multivariate linear mixed model, 
and excluding these patients did not materially change 
the magnitude or direction of our univariate findings.
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Arterial blood gas parameters
Arterial blood gas values at the three different time points 
are shown in Table 2. PaO2 levels pre- and post-hyperoxia 
matched well with the targeted levels. Also, pre- and 
post-hyperoxia arterial oxygen saturation (SaO2) was 
similar. During hyperoxia PaO2 and SaO2 were signifi-
cantly higher.
PaCO2 decreased over time, whereas hemoglobin, 
hematocrit, glucose and lactate levels did not change.
Hemodynamic parameters
Hemodynamic values at the three different time points 
are shown in Table 3. After starting the intervention with 
90% oxygen supply, Rsys increased (P  <  0.0001), without 
altering the heart rate. SVV and PPV decreased slightly. 
CO did not significantly decrease (P = 0.08).
During the hyperoxia period Pmsf and the slope of 
the venous return curve (Slopevrc) increased (Fig.  1). 
Pcc increased, whereas the slope of the left ventricu-
lar output curve (Slopevoc) did not change. Rsys and Rvr 
increased because of the higher MAP and Pmsf at con-
stant CO. Rvo did not change because MAP and Pcc 
increased similarly.
We did not find any reduction in cerebral blood flow 
and only slight shifts in microcirculatory scores were 
noted. The percentage of perfused vessels decreased dur-
ing hyperoxia (P = 0.01). No changes in vascular density 
were detected for either large or small vessels.
The results were virtually unchanged when multivariate 
mixed models were used (Table 3).
Discussion
In this single-center physiological intervention study, we 
found that a 15-min exposure to hyperoxia affects hemo-
dynamics in ICU patients after CABG. This was trans-
lated in several changes in central circulatory variables 
and in the percentage of perfused microcirculatory ves-
sels, but showed no alterations in cardiac output and cer-
ebral blood flow.
The circulation of blood can be described by either 
the CO or the venous return. As only blood returning to 
the heart can be pumped out in the systemic circulation, 
venous return should always equal CO. Major determi-
nants of CO are preload, contractility and afterload. Dur-
ing hyperoxia, left ventricular afterload clearly increased. 
The absence of a measurable decrease in CO may be 
explained by a concomitant increase in preload. Indeed, 
we found higher CVP during hyperoxia. The alternative 
explanation, i.e., increased contractility, is unlikely as we 
found no increase in the slope of the cardiac output curve 
during hyperoxia.
The circulation can also be described by the venous 
return to the heart, which is driven by Pmsf − CVP. Dur-
ing hyperoxia Pmsf increased more than CVP. However, 
this did not lead to an increase of venous return due to 
the simultaneous increase in venous resistance.
Table 1 Patient characteristics
Data are medians (interquartile range), unless stated otherwise
BMI body mass index, APACHE Acute Physiology and Chronic Health Evaluation 
Score, SAPS Simplified Acute Physiology Score, Pinsp inspiratory pressure, VT tidal 
volume, PEEP positive end-expiratory pressure
Characteristics All patients (n = 22)
Descriptive characteristics
 Age (year) 63 (59–66)
 Male/female (n) 17/5
 BMI (kg/m2) 26 (25–29)
 Body temperature (°C) 37 (36–37)
 APACHE IV 40 (33–61)
 SAPS II 28 (24–32)
Surgical characteristics
 Perfusion time (min) 105 (91–121)
 Clamp time (min) 73 (63–82)
ICU ventilator settings
 Pinsp (cm H2O) 18 (16–19)
 VT (ml) 585 (484–650)
 PEEP (cm H2O) 5 (5–5)
 Respiratory rate (breaths min−1) 12 (12–14)
ICU medication
 Propofol (mg h−1) 250 (200–288)
 Sufentanil (mg h−1) 10 (6–10)
 Norepinephrine (µg kg−1 min−1) 0 (0–0), range 0–0.04
Table 2 Variables of arterial blood gas analyses during dif-
ferent time periods
Data are means (SD). For FiO2, medians (interquartile range) are provided
FiO2 fraction of inspired oxygen, SaO2 arterial oxygen saturation, PaO2 partial 
pressure of arterial oxygen, PaCO2 partial pressure of arterial carbon dioxide, Hb 
hemoglobin, Ht hematocrit
* P < 0.01; ** P < 0.001; *** P < 0.0001 for paired comparison between indicated 
outcome and baseline (T1)
a Arterial blood gas samples analyzed prior to the start of hemodynamic 
measurement
Variable T1 T2 T3
Pre Hyperoxia Post
FiO2 (%) 25 (21–30) 90 (90–90) 21 (21–25)
Arterial blood gas analysesa
 SaO2 (%) 94.9 (1.9) 99.0 (0.3)*** 95.7 (1.8)
 PaO2 (mmHg) 83.5 (12.2) 390.2 (93.2)*** 87.8 (21.5)
 PaCO2 (mmHg) 39.8 (8.1) 36.0 (7.9)** 34.5 (8.7)***
 Hb (mmol L−1) 7.2 (0.8) 7.4 (0.7) 7.4 (0.8)
 Ht (L L−1) 0.34 (0.04) 0.35 (0.03) 0.35 (0.04)
 Glucose (mmol L−1) 7.5 (1.6) 7.4 (1.7) 7.7 (1.8)
 Lactate (mmol L−1) 1.25 (0.38) 1.20 (0.40) 1.25 (0.34)
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Table 3 Crude hemodynamic measurements during different time periods and adjusted change in estimate with hyper-
oxic ventilation
Change in estimate (95% CI) with intervention (hyperoxia) in reference to normoxia periods from linear mixed model adjusted for age, temperature, Hb, PaCO2, 
norepinephrine dose and propofol dose. P value calculated using t tests with Satterthwaite approximations to degrees of freedom
Data are means (SD). For PV (%), medians (interquartile range) are provided
MAP mean arterial pressure, CVP central venous pressure, HR heart rate, CO cardiac output, SVV stroke volume variation, PPV pulse pressure variation, Rsys resistance of 
the systemic circulation, Pvr pressure difference between Pmsf and Pcv, Rvr resistance for venous return, Slopevrc slope of venous return curve, Pmsf mean systemic filling 
pressure, Rvo resistance for ventricular output, Slopevoc slope of ventricular output curve, Pcc critical closing pressure, BFVmca blood flow velocity in middle cerebral 
artery, RBC red blood cell, PBR perfused boundary region, TVD total vascular density, PVD perfused vascular density, VVD valid vascular density, PV perfused vessels
* P < 0.01; ** P < 0.001; *** P < 0.0001 for paired comparison between indicated outcome and baseline (T1)
a Directly measured from radial artery and central venous catheters
b Calculated beat-to-beat by pulse contour analysis from Modelflow and averaged over indicated time period
c Calculated by pulse contour analysis from LiDCOplus 15 min after starting the exposure at indicated time period
d Secondarily derived from Modelflow calculated variables
e Directly measured using transcranial Doppler on middle cerebral artery
f Calculated from sublingual sidestream dark field imaging analyses
Hemodynamic variables T1 T2 T3 Hyperoxia vs. normoxia P value
Pre Hyperoxia Post Adjusted change in estimate (95% CI)
Central circulatory variablesa
 MAP (mmHg) 77 (11) 85 (11)*** 78 (11) 6.76 (3.88; 9.63) <0.0001
 CVP (mmHg) 9.1 (1.7) 9.6 (1.7) 9.3 (1.6) 0.35 (0.11; 0.60) 0.01
 HR (beats min−1) 84 (14) 82 (14) 83 (15) −0.55 (−3.05; 2.06) 0.68
Calculated variables
 CO Modelflow (L min−1)b 5.12 (1.04) 4.97 (1.13) 4.98 (1.18) −0.08 (−0.27; 0.11) 0.41
 SVV (%)b 13.6 (9.3) 13.2 (6.9) 15.3 (7.4) −1.76 (−3.38; −0.03) 0.05
 PPV (%)b 15.6 (10.3) 15.1 (7.6) 16.6 (4.9) −1.30 (−2.99; 0.49) 0.16
 CO LiDCOplus (L min−1)c 4.80 (1.10) 4.62 (1.10) 4.79 (1.27) −0.12 (−0.40; 0.08) 0.21
Derived parametersd
 Rsys (mmHg min L
−1) 13.4 (4.9) 15.3 (5.9)*** 13.6 (5.1) 1.82 (0.96; 2.67) <0.001
 Pvr (mmHg) 11.7 (3.3) 13.5 (3.5)* 12.1 (2.8) 1.47 (0.61; 2.37) <0.01
 Rvr (mmHg min L
−1) 2.4 (0.8) 2.8 (1.0)** 2.5 (0.8) 0.39 (0.21; 0.58) <0.001
 Slopevrc (L min
−1 mmHg−1) −0.46 (0.16) −0.38 (0.13)** −0.44 (0.15) 0.07 (0.03; 0.10) <0.001
 Pmsf (mmHg) 20.8 (3.5) 23.1 (4.0)* 21.4 (2.9) 1.90 (0.95; 2.93) <0.001
 Rvo (mmHg min L
−1) 7.9 (3.2) 7.9 (4.3) 7.7 (1.9) −0.09 (−1.17; 1.03) 0.87
 Slopevoc (L min
−1 mmHg−1) 0.13 (0.05) 0.15 (0.11) 0.14 (0.04) 0.01 (−0.03; 0.05) 0.62
 Pcc (mmHg) 38.8 (9.8) 47.9 (15.1)* 40.9 (8.9) 8.55 (4.13; 12.68) <0.001
Cerebral blood flowe
 BFVmca (cm s
−1) 34.6 (10.6) 32.3 (10.3) 33.6 (11.5) −1.42 (−3.80; 1.01) 0.26
 Pulsatility index 0.95 0.96 1.0 −0.03 (−0.07; 0.01) 0.17
 Resistance index 0.57 0.57 0.58 0 (−0.01; 0.01) 0.66
Microcirculationf
 RBC filling (%) 72.3 (4.4) 71.1 (5.0) 72.9 (5.1) −1.87 (−3.29; −0.34) 0.02
 PBR (µm) 2.1 (0.2) 2.2 (0.2) 2.1 (0.2) 0.05 (−0.03; 0.12) 0.21
 TVD (mm/mm2) 12.2 (3.5) 12.7 (3.5) 12.0 (3.4) 0.35 (−0.96; 2.08) 0.66
 PVD (mm/mm2) 12.0 (3.7) 12.1 (2.9) 12.0 (3.1) −0.03 (−1.50; 1.70) 0.97
 VVD (µm/mm2) 712 (117) 672 (130) 699 (93) −37.29 (−80.97; 8.01) 0.11
 De Backer Score (n/mm) 14.2 (1.2) 15.1 (1.6) 14.4 (1.6) 0.86 (0.23; 1.51) 0.01
 PV (%) 99.6 (1.3) 93.2 (8.3)* 97.4 (6.1) −4.72 (−7.64; −2.00) <0.01
100 (IQR 99–100) 98 (IQR 85–100) 100 (IQR 99–100) – –
 Heterogeneity index (%) 13 [9–14] 22 [21–23]*** 21 [15–21]*** – –
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Vasoconstriction may be the key driver of most if not 
all effects of hyperoxia on hemodynamics. Not only does 
it increase blood pressure, afterload and venous resist-
ance, it also leads to a shift of blood from unstressed to 
stressed volume, as indicated by increases in Pmsf and 
CVP. We also observed an increase in Pcc by hyperoxia. 
Pcc is a theoretical pressure defined by dynamic pres-
sure flow-relations and represents the arterial pressure, 
below which conceptually no flow will be possible. It is 
a combined estimate representing all vascular circuits. 
Theoretically, Pcc is the sum of arterial wall tension and 
the pressure surrounding the blood vessel. Pcc may dif-
fer importantly between different vessels, and measured 
Pcc is an average value for the complete vasculature. An 
increase in Pcc may be especially relevant in certain dis-
ease states such as increased intracranial pressure and 
abdominal compartment syndrome with high pressures 
surrounding the vessels. In both situations, Pcc is mark-
edly elevated. For example, intracerebral blood flow will 
decrease to zero when arterial blood pressure is lower 
than the critical closing pressure of the brain and beyond 
the limits of cerebral autoregulation. In such states, vaso-
constriction, by either vasoactive drugs or hyperoxia, 
may have either beneficial effects by increasing blood 
pressure or harmful effects by increasing arterial wall 
tone and thereby Pcc.
In our study, we could not show a reduction in perfu-
sion of the brain by hyperoxia. Similarly, in a previous 
report perfusion changes at all oxygen levels were rela-
tively small [27, 28]. It should be noted that all these stud-
ies were performed in situations with normal intracranial 
pressure. In  situations with intracranial hypertension, 
such as in traumatic brain injury, we cannot rule out that 
a further increase of Pcc by hyperoxia will decrease the 
pressure difference between Pa and Pcc which can lead to 
a lower perfusion and possible ischemia of the brain.
Comparing our findings with earlier studies on the 
effects of hyperoxia on hemodynamics, the cardiac out-
put fall was less than in healthy volunteers [29] and the 
decrease in the percentage of perfused vessels of the 
microcirculation was also in a different order of mag-
nitude than previously observed [30]. Recognizing the 
perfused boundary region of microcirculatory vessels as 
a surrogate measure for the dimension of the glycocalyx, 
we could not detect any hyperoxia-induced alterations. 
Considering the effects on the venous system, more pro-
nounced effects are to be expected in the smaller vessels 
compared to larger vessels. As a limited number of arte-
rioles are present in the sublingual mucosa, where capil-
laries and venules are more abundant, only slight changes 
were anticipated in the analyzed microcirculation when 
high oxygen levels are applied.
Fig. 1 Venous return and ventricular output curves by arterial oxygenation status. Relationship between cardiac output (CO) and central venous 
pressure (CVP) in a venous return curve and between CO and mean arterial blood pressure (MAP) in a ventricular output curve for the averaged 
patient (Table 3). At zero blood flow mean systemic filling pressure (Pmsf) and critical closing pressure (Pcc) are indicated. Venous return curves and 
ventricular output curves for arterial normoxia and hyperoxia are given
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Study differences may be largely explained by the use 
of anesthesia and mechanical ventilation as both affect 
hemodynamics and anesthesia also induces a considera-
ble decrease in stressed volume. Furthermore, even in the 
presence of healthy lungs, both mechanical ventilation 
and bypass surgery may inflict an inflammatory response 
which can modify the effects of hyperoxic ventilation 
on the circulation in comparison with healthy subjects. 
Remaining differences may be clarified by the short expo-
sure time in our procedures, although no further increase 
in PaO2 was to be expected from a longer exposure and 
therefore a steady state in hemodynamics was assumed.
The increase in stressed volume and Pmsf by hyper-
oxia mimics the effects of administering a fluid bolus, 
yet without increasing the Rvr. It is well known that the 
effects of extra fluids on CO are most pronounced in sit-
uations with underfilling of the vasculature explaining 
the relative conservation of cardiac output during hyper-
oxia in our postoperative, sedated patients, compared to 
healthy subjects. The effects of hyperoxia closely resem-
ble the effects of norepinephrine and are in contrast to 
the effects of propofol [31, 32]. We earlier showed that 
intravenous administration of norepinephrine resulted in 
increases in Rsys, Rvr and Pmsf. Interestingly, CO increased 
in some but not all patients after norepinephrine [32]. An 
increase in CO was associated with a higher SVV. Thus, 
it appears likely that the effects of a shift from unstressed 
to stressed volume by vasoconstriction, with an increase 
in Pmsf, is mostly found in patients with vasoplegia and/
or a decreased circulating volume. Hence, the effects of 
hyperoxia on CO are determined by the balance between 
volume recruitment (Pmsf) and change in Rvr and baseline 
heart function, as observed before [32]. Although our 
results clearly indicate that hyperoxia increases venous 
resistance by venous vasoconstriction and that left ven-
tricular output resistance (Rvo) did not change, we must 
realize that our description of the circulation is not com-
plete. We cannot describe the part between the site where 
Pcc exists and the site where Pmsf exists. Therefore, there 
is a missing part of the circulatory circuit, i.e., the distal 
arterial compartment, where control of the peripheral 
circulation is performed by the pre-capillary sphincters.
A recent study with an alternative cardiac output moni-
tor of the arterial pressure wave showed a poor correla-
tion with the thermodilution obtained CO values while 
changing norepinephrine doses [33]. However, measure-
ments carried out by our group suggest that the Mod-
elflow technique is capable of measuring the effects 
induced by vasoconstriction in an accurate manner [32], 
suggesting that vasoactive agents may not importantly 
affect the precision of your technology. This was also 
underlined by the CO values measured by the LiDCO-
plus monitor that showed a similar pattern compared 
to the Modelflow technique in our study. Furthermore, 
the determination of Pmsf is not dependent on the accu-
racy of the Modelflow technique. Indeed, extrapolation 
of the venous return curve to flow zero is independent 
of absolute cardiac output. The ability to follow changes 
in cardiac output within a patient has been clearly dem-
onstrated before [18]. We also showed that beat-to-beat 
changes in Modelflow cardiac output follows cardiac 
output by beat-to-beat analysis of electromagnetic probe 
flow signals [19].
Acknowledging that our findings are to be reproduced 
in a larger cohort and different clinical settings, the fol-
lowing study aspects should be considered. First, the 
small sample size and the specific subgroup of patients 
do not warrant a broad generalizability for the observed 
effects. Hemodynamics in the current patient group 
may be affected by the effects of the recent bypass and 
the potential mediators of ischemia reperfusion and 
inflammation. Other subsets of critically ill patients 
may respond differently than patients in our cohort who 
were in a relatively stable condition before starting study 
procedures. Two patients received small doses of nor-
epinephrine during the experiment to keep the blood 
pressure in the same order of magnitude as the other 
included patients but showed stable hemodynamics and 
the dose was not changed throughout the experiment. 
Also, excluding these patients from our analyses showed 
virtually no change in our results.
There may be a time effect in which recovery and sta-
bilization of patients in the ICU after surgery may influ-
ence hemodynamics. However, assuming that the effect 
of hyperoxia was transient and respecting a 15-min time 
gap between the two exposures, the carryover effect 
was minimized and each case served as its own control 
(self-matched) [34]. Adjusted changes in estimates were 
based on within-subject comparisons of exposure to 
hyperoxia with exposure to normoxia. Sampling bias was 
minimized by continuously measuring central circulatory 
variables, which provide a highly accurate representation 
of the parameters over the time periods. Cerebral blood 
flow, microcirculation and parameters assessed from the 
inspiratory hold procedures were measured intermit-
tently, yet at representative sampling moments during 
the sequential time points and averaged as appropriate.
Since we could not detect large differences between the 
outcomes of univariate and multivariate statistical mod-
els accounting for repeated measurements, the observed 
effects may be predominantly attributed to hyperoxic 
ventilation, rather than to concomitant changes in other 
parameters. Other covariates that were considered, such 
as PaCO2, are therefore not a likely explanation for the 
hemodynamic changes as seen during the experiment. 
While a short period of supraphysiological arterial 
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oxygenation may disturb the hemodynamic balance, the 
effects of long-term exposure to hyperoxia are still uncer-
tain but may be essential regarding patient-centered 
outcomes.
Conclusions
Short-term hyperoxia after cardiac surgery induces sig-
nificant alterations in systemic circulation mainly by 
vasoconstriction of both the venous and arterial circu-
lation and an increase of mean systemic filling pressure. 
The increase in stressed volume and systemic filling pres-
sure by hyperoxia resembles the effects of administering 
a fluid bolus or norepinephrine. This may have clinically 
important consequences in critically ill patients when 
hemodynamic and microcirculatory changes are vital, 
but the effects were not clearly linked to relevant changes 
in cardiac output and cerebral blood flow.
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